Logo
x

Search category

Subscribe Now

All Posts by Date

AstraZeneca’s Imfinzi (durvalumab) + Imjudo (tremelimumab) Receive MHLW’s Approval for Advanced Liver and Non-Small Cell Lung Cancers

AstraZeneca’s Imfinzi (durvalumab) + Imjudo (tremelimumab) Receive MHLW’s Approval for Advanced Liver and Non-Small Cell Lung Canc...

  • December 29, 2022
PharmaShots' Key Highlights of Fourth Quarter 2022

PharmaShots' Key Highlights of Fourth Quarter 2022

  • December 29, 2022
Junshi Biosciences Reports P-III Clinical Trial Results of VV116 for Severe COVID-19

Junshi Biosciences Reports P-III Clinical Trial Results of VV116 for Severe COVID-19

  • December 29, 2022
TG Therapeutics’ Briumvi (ublituximab-xiiy) Receives the US FDA’s Approval for Relapsing Multiple Sclerosis

TG Therapeutics’ Briumvi (ublituximab-xiiy) Receives the US FDA’s Approval for Relapsing Multiple Sclerosis

  • December 29, 2022
Mitsui to Acquire Sumitomo Pharma Animal Health

Mitsui to Acquire Sumitomo Pharma Animal Health

  • December 29, 2022
Pfizer’s BLA for MenABCWY is Accepted by the US FDA as Preventive Measure for Meningococcal Disease

Pfizer’s BLA for MenABCWY is Accepted by the US FDA as Preventive Measure for Meningococcal Disease

  • December 29, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.